| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8214939 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 8 Pages |
Abstract
Our single-institution study with a median 8-year follow-up showed that HDR-BT as monotherapy was safe and effective for patients with intermediate- and high-risk prostate cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Yasuo MD, Osamu MD, Fumiaki MD, Yuji MD, Hirofumi MD, Hiroko MD, Michio MS, Yuki PhD, Iori PhD, Motohide MD, Kazutoshi MD, Akira MD, Takeshi MD, Atsunari MD, Ken MD, Hideya MD, Norio MD, Kazuhiko MD,